Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined...
Patent
1996-07-16
1999-10-05
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
424572, 424451, 424464, 514801, 530356, A61K 3512
Patent
active
059620250
ABSTRACT:
The present invention is directed to a method and pharmaceutical formulations for the treatment of systemic sclerosis in mammals, by oral administration of collagen, including type I collagen, or biologically active peptide fragments thereof.
REFERENCES:
patent: 4444752 (1984-04-01), Prudden
patent: 5399347 (1995-03-01), Trentham et al.
Wardale et al., Quantification and immunolocalisation of porcine articular and growth plate cartilage collagens, J. Cell Sci. 105:975-984, 1993.
Mosmann et al., The role of IL-10 in crossregulation of TH1 and TH2 responses, Immunology Today, 12:A49-A53, 1991.
Fiocco et al., Early phenotypic activation of circulating helper memory T cells in scleroderma: correlation with disease activity, Ann. Rheum. Dis., 52:272-277, 1993.
Dawnay et al., Microalbuminuria in systemic sclerosis, Ann. Rheum. Dis., 51:384-388, 1992.
Clements et al., Inter and intraobserver variability of total skin thickness score (Modified Rodnan TSS) in systemic sclerosis, J. Rheumatol., 22:1281-1285, 1995.
Clements et al., Health Assessment Questionnaire (HAQ) in patients with early, diffuese cutaneous systemic sclerosis (SSc), Arthritis and Rheumatism, 37(9)Suppl:S260, Abstract #603, 1994.
Dawnay et al., 1992, "Microalbuminuria in Systemic Sclerosis," Ann. Rheumatic Diseases 51:384-388.
Fiocco et al., 1993, "Early Phenotypic Activation of Circulating Helper Memory t Cells in Scleroderma: Correlation with Disease Activity," Ann. Rheumatic Diseases 52:272-277.
Mosmann et al., 1991, "The Role of IL-10 in Crossregulation of T.sub.H 1 and T.sub.H 2 Responses," Immunology Today 12:A49-A53.
Flick et al., 1988, "Esophageal Motor Abnormalities in Children and Adolescents with Scleroderma and Mixed Connective Tissue Disaeas", Pediatrics 82:107-111.
Garty et al., 1991, "Pulmonary Functions in Children with Progressive Systemic Sclerosis", Pediatrics 88:1161-1167.
Kagnoff, M.F., 1982, "Oral Tolerance", Ann. NY Acad. Sci. 392:248-265.
Lider et al., 1989, "Suppression of Experimental Autoimmune Encephalomyelitis by Oral Administration of Myelin Basic Protein", J. Immunol. 142:748-752.
Nagler-Anderson et al., 1986 "Suppression of Type II Colagen-induced Arthritis by Intragastric Administration of Soluble Type II Collagen", Proc. Natl. Acad. Sci. U.S.A. 83:7443-7446.
Nussenblatt et al., 1990, "Inhibition of S-Antigen Induced Experimental Autoimmune Uveoretinitis by Oral Induction of Tolerance with S-Antigen", J. Immunol. 144:1689-1695.
Pai et al., 1995, "Efficacy of Dexamethasone Pulse Therapy in Progressive Systemic Sclerosis", Int. J. Dermatol. 34(10):726-728.
Trentham et al., "Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis", 1993, Science 261:1727-1730.
Vallance et al., 1995, "Immunosuppressive Treatment of the Pulmonary Manifestations of Progressive Systemic Sclerosis",O Curr. Opin. Rheumatol. 7(3):174-182.
Weiner et al., 1993, "Double-blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis", Science 259:1321-1324.
Wilson et al., 1995, J. Dermatol. 22(9):637-42.
Zhang et al., 1991, "Suppression of Diabetes in Nonobese Diabetic Mice by Oral Administration of Porcine Insulin", Proc. Natl. Acad. Sci. U.S.A. 88:10252-10256.
Carbone Laura
Kang Andrew H.
McKown Kevin
Postlethwaite Arnold E.
Seyer Jerome M.
Eisenberg, Esq. Howard
Kerr Janet M.
The University of Tennessee Research Corporation
Wityshyn Michael G.
LandOfFree
Method for treatment of systemic sclerosis and related fibrotic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of systemic sclerosis and related fibrotic , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of systemic sclerosis and related fibrotic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1168695